DreaMed Diabetes, the developer of personalised diabetes management solutions, has launched a virtual diabetes management service to treat people with type 1 diabetes remotely.
The virtual diabetes management service gives people with type 1 diabetes access to medical professionals ensuring treatment remains unaffected by widespread COVID-19-induced quarantines.
Although most healthy people might find themselves at low risk for complications by contracting COVID-19, others are far more vulnerable. The CDC reported that people with chronic medical conditions, including diabetes, are at greater risk of complications should they contract the virus, and as a result, patients with diabetes have been forced to skip routine visits with healthcare professionals and neglect their treatment.
DreaMed virtual diabetes management service enables people with diabetes to receive treatment from a distance, allowing them to stay safe from potential infection in public areas. The virtual diabetes management service will use the DreaMed Advisor decision support technology to improve the insulin management treatment of patients.
DreaMed Advisor is an advanced decision-support tool, which generates insulin-delivery recommendations by analysing the patient’s insulin and glucose data in the platform’s algorithm. Advisor applies event-driven adaptive learning to refine its understanding for each individual case. The solution, which was evaluated at a multi-centre study at Joslin Diabetes Center, the University of Florida, Yale University, and Barbara Davis Center for Diabetes, provides recommendations to the healthcare provider on how to optimise a patient’s insulin pump settings for basal rate, carbohydrate ratio, and insulin sensitivity.
Eran Atlas, DreaMed co-founder and CEO, said: “We are very proud to be launching our virtual diabetes management service, continuing our mission to provide healthcare professionals with a reliable, automated decision-support tool that empowers every patient with the best care possible. With the Coronavirus pandemic sweeping across the globe, we realise more than ever the need to have remote, telemedicine treatment options to ensure as many people as possible, especially those with diabetes, are safe from potential infection and have access to the care they need.”
